CDMRP Amyotrophic Lateral Sclerosis (ALS) Therapeutic Development Award
|קרן||US Department of Defense|
|פקולטה||Exact Sciences, Life Sciences, Medicine|
The Therapeutic Development Award supports a wide range of development activities ranging from validation of therapeutic leads to FDA New Drug (IND) submission. The proposed studies are expected to be empirical in nature and product-driven. Applications supported by this award must begin with lead compounds in hand.
It is expected that 3 grants will be awarded this year.
Funding: $1,000,000 total
Duration: 3 years
Research Authority due date: 21.3.21
Pre application (required) due date: 9.4.21
Full application due date: 15.7.21
|עדכון אחרון||עדכון אחרון: 17/02/2021|